title: Patients with HIV with Burkitt's lymphoma have a worse outcome than those with diffuse large-cell lymphoma also in the highly active antiretroviral therapy era.
authors.forename: Michele
authors.initials: M
authors.lastname: Spina
authors.forename: Cecilia
authors.initials: C
authors.lastname: Simonelli
authors.forename: Renato
authors.initials: R
authors.lastname: Talamini
authors.forename: Umberto
authors.initials: U
authors.lastname: Tirelli
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D002051:Burkitt Lymphoma / Q000401:mortality*; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000401:mortality*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000401:mortality*; D016896:Treatment Outcome